Pharmaceuticals (Oct 2022)

Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2<i>H</i>)-one as Novel Scaffold for FABP4 Inhibition

  • Letizia Crocetti,
  • Giuseppe Floresta,
  • Chiara Zagni,
  • Divya Merugu,
  • Francesca Mazzacuva,
  • Renan Rodrigues de Oliveira Silva,
  • Claudia Vergelli,
  • Maria Paola Giovannoni,
  • Agostino Cilibrizzi

DOI
https://doi.org/10.3390/ph15111335
Journal volume & issue
Vol. 15, no. 11
p. 1335

Abstract

Read online

Fatty acid binding protein (FABP4) inhibitors are of synthetic and therapeutic interest and ongoing clinical studies indicate that they may be a promise for the treatment of cancer, as well as other diseases. As part of a broader research effort to develop more effective FABP4 inhibitors, we sought to identify new structures through a two-step computing assisted molecular design based on the established scaffold of a co-crystallized ligand. Novel and potent FABP4 inhibitors have been developed using this approach and herein we report the synthesis, biological evaluation and molecular docking of the 4-amino and 4-ureido pyridazinone-based series.

Keywords